miR-590�5p: A double-edged sword in the oncogenesis process

dc.contributor.authorBarwal, Tushar Singh
dc.contributor.authorSingh, Neha
dc.contributor.authorSharma, Uttam
dc.contributor.authorBazala, Sonali
dc.contributor.authorRani, Medha
dc.contributor.authorBehera, Alisha
dc.contributor.authorKumawat, Ram Kumar
dc.contributor.authorKumar, Pawan
dc.contributor.authorUttam, Vivek
dc.contributor.authorKhandelwal, Akanksha
dc.contributor.authorBarwal, Jyoti
dc.contributor.authorJain, Manju
dc.contributor.authorJain, Aklank
dc.date.accessioned2024-01-16T14:23:14Z
dc.date.accessioned2024-08-13T10:34:11Z
dc.date.available2024-01-16T14:23:14Z
dc.date.available2024-08-13T10:34:11Z
dc.date.issued2022-06-12T00:00:00
dc.description.abstractAccumulating evidence suggests the critical role of miR-590�5p in various aspects of cellular homeostasis, including cancer. Furthermore, we and others have recently demonstrated that miRNA-590�5p acts as an oncogene in some cancers while it acts as a tumor-suppressor in others. However, the role of miR-590�5p in oncogenesis is more complex, like a double-edged sword. Thus, this systematic review introduces the concept, mechanism, and biological function of miR-590�5p to resolve this apparent paradox. We have also described the involvement of miR-590�5p in crucial cancer-hallmarks processes like proliferation, invasion, metastasis, and chemo radioresistance. Finally, we have presented the possible genes/pathways targets of miR-590�5p through bioinformatics analysis. This review may help in designing better biomarkers and therapeutic targets for cancers. � 2022en_US
dc.identifier.doi10.1016/j.ctarc.2022.100593
dc.identifier.issn24682942
dc.identifier.urihttps://doi.org/10.1016/j.ctarc.2022.100593
dc.identifier.urihttp://10.2.3.109/handle/32116/2882
dc.language.isoen_USen_US
dc.publisherElsevier Ltden_US
dc.subjectBiomarkeren_US
dc.subjectCanceren_US
dc.subjectMicroRNAen_US
dc.subjectmiR-590-5pen_US
dc.subjectTherapeutic targeten_US
dc.titlemiR-590�5p: A double-edged sword in the oncogenesis processen_US
dc.title.journalCancer Treatment and Research Communicationsen_US
dc.typeReviewen_US
dc.type.accesstypeOpen Accessen_US

Files